Schiff, Abigail E.
Linder, Alice H.
Luhembo, Shillah N.
Banning, Stephanie
Deymier, Martin J.
Diefenbach, Thomas J.
Dickey, Amy K.
Tsibris, Athe M.
Balazs, Alejandro B.
Cho, Josalyn L.
Medoff, Benjamin D.
Walzl, Gerhard
Wilkinson, Robert J.
Burgers, Wendy A.
Corleis, Björn
Kwon, Douglas S.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (F30HL134566-02, U01HL121827, U01HL121827)
National Institute of General Medical Sciences (T32GM007753)
National Institute on Drug Abuse (DP2DA040254, DP2DA040254)
MGH Transformative Scholars Program
Charles H. Hood Foundation
Gilead Sciences
National Institute of Allergy and Infectious Diseases (R01AI108538)
South African National Research Foundation (86535, 96841)
South African Tuberculosis Bioinformatics Institute
Wellcome Trust (203135, #089832/Z/09/Z)
Cancer Research UK (FC001028)
UK Research and Innovation (FC001028)
European Union (FP7-Health-F3-2012–305578)
Strategic Health Innovation Partnership
Horizon 2020 Framework Programme (TMA2016SF-1535)
Burroughs Wellcome Fund
Article History
Received: 11 March 2020
Accepted: 8 December 2020
First Online: 16 February 2021
Competing interests
: The authors declare no competing interests.